Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

A new study from Northwestern University has found that two widely prescribed type 2 diabetes medications—sulfonylureas and ...

The Oklahoma Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs used for weight loss and diabetes management. Called GLP-1 agonists and used ...

Inositol supplements show significant benefits for hormonal disorders, insulin sensitivity, and fertility issues, offering a ...

What are the key medical considerations for people with diabetes who wish to fast during Ramadan and how can they assess ...

For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...

WEIGHT loss jabs have become the latest fad for changing your appearance. It seems as though half of Hollywood is using ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes. CATT1 Phase 3 trial expected to ...

The Affordable Insulin Now Act, as it is known ... Unfortunately, the current drug pricing bill fails to take a holistic approach to addressing a system that drives affordability challenges ...

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Amid the soaring use of glucagon-like peptide-1 (GLP-1) drugs for intentional weight loss, a vastly different movement appears to be gaining traction in health care: Many clinicians are pushing for a ...